GENDER PREVALENCE IN CELIAC DISEASE
Abstract
Objective: There is no data showing which gender is predominantly affected by ce-
liac disease (CD) available from Pakistan. This study was aimed to determine which
gender is more affected by celiac disease.
Material and methods:
This cross sectional study was performed at Fatima Memo-rial Hospital, Lahore-Pakistan. 121 patients were recruited in the study according
to the inclusion and exclusion criteria. Every patient went through upper gastro-
intestinal endoscopy, as duodenal biopsy is the gold standard of the diagnosis.
Histopathological evaluation was done according to Modified Marsh classifica-
tion.
Results:
Out of 121 patients, 14 were diagnosed to have celiac disease. Out of
14 patients 11 (78.5%) were females and 3 (21.5%) were males.
Conclusions:
Females are predominantly associated with celiac disease with female to male ratio of3.6:1.
References
Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated alogrithms.Am J Med 2010; 123(8):691-3.
Licata A. Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions. Intern Emerg Med 2011; 7(4):337-42.
Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S et al. The prevalence of celiac disease in Eu-rope: results of a centralized, international mass screen-ing project. Ann Med 2010; 42(8): 587-95.
Van der Windt DA. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA 2010; 303(17):1738-46.
Ciacci C, Cirillo M, Sollazzo R, Savino G, Sabbatini F, Maz-zacca G. Gender and clinical presentation in adult celiac disease. Scand J Gastroenterol 1995; 30(11):1077-81.
Murray J, Van C, Plevak F, Dierkhising A, Zinsmeister R, Melton J. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. ClinGastroenterolHepatol2003; 1(1):19-27.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Arsalan Javaed
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
. 
